T. Tashi

发表

I. Aldoss, T. Tashi, A. Ganti, 2009, Expert opinion on investigational drugs.

Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population.

I. Aldoss, T. Tashi, A. Ganti, 2011, Journal of palliative medicine.

Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders

L. Moore, P. Koul, C. Huff, 2017, Journal of Molecular Medicine.

Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses

M. Salama, J. Prchal, T. Tashi, 2018, Leukemia.

Presence of Polyclonal Hematopoiesis in Females with Ph-negative Myeloproliferative Neoplasms

J. Prchal, T. Tashi, Soo Jin Kim, 2015, Leukemia.

Calreticulin mutated prefibrotic-stage myelofibrosis and PMF represent an independent clone from coexisting CLL.

M. Salama, J. Prchal, T. Tashi, 2014, Blood.

Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian Amazon

J. Rayner, R. Longley, W. Tham, 2022, medRxiv.

Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia.

J. Prchal, T. Tashi, K. Sundar, 2020, Blood advances.

Chapter 12 – Polycythemia

J. Prchal, T. Tashi, 2016 .

Phlebotomy-Induced Iron Deficiency Increases the Expression of Prothrombotic Genes

J. Prchal, T. Tashi, V. Gordeuk, 2020 .

Editorial Comment on: Inhibition of Suicidal Erythrocyte Death by Chronic Hypoxia by Tang et al. (From: Tang F, Feng L, Li R, Wang W, Liu H, Yang Q, Ge R-L. High Alt Med Biol 2019;20:112-119; DOI: 10.1089/ham.2017.0159).

J. Prchal, T. Tashi, Jihyun Song, 2019, High altitude medicine & biology.

Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers.

L. Jorde, J. Rodriguez-Flores, B. Welm, 2021, Blood cancer discovery.

Intracranial Inflammatory Myofibroblastic Tumor with Sarcomatous Local Recurrence.

T. Tashi, C. Shy, E. Hsueh, 2016, World neurosurgery.

Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: A veterans' affairs central cancer registry (VACCR) database analysis

I. Aldoss, T. Tashi, A. Ganti, 2011, Journal of surgical oncology.

Laparoscopically assisted vaginal hysterectomy for large uterus: a comparative study.

Y. Soong, T. Tashi, C. Yen, 2004, European journal of obstetrics, gynecology, and reproductive biology.

A genetic mechanism for Tibetan high-altitude adaptation

G. Semenza, L. Jorde, P. Koul, 2014, Nature Genetics.

High altitude genetic adaptation in Tibetans: no role of increased hemoglobin-oxygen affinity.

P. Koul, J. Prchal, T. Tashi, 2014, Blood cells, molecules & diseases.

Evolutionary history of Tibetans inferred from whole-genome sequencing

L. Hood, J. Roach, L. Jorde, 2017, PLoS genetics.

Congenital and evolutionary modulations of hypoxia sensing and their erythroid phenotype

J. Prchal, T. Tashi, Jihyun Song, 2019, Current Opinion in Physiology.

Trends in overall mortality among US veterans with primary myelofibrosis

T. Tashi, R. Scherber, S. Parasuraman, 2023, BMC Cancer.

Hematocrit, White Blood Cells, and Thrombotic Events in the Veteran Population With Polycythemia Vera.

T. Tashi, 2022, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

A Genome-Wide Search for Greek and Jewish Admixture in the Kashmiri Population

L. Jorde, P. Koul, J. Prchal, 2016, PloS one.

Treatment of small cell lung cancer

T. Tashi, A. Ganti, W. Gonsalves, 2011 .

P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS

T. George, D. DeAngelo, T. Tashi, 2022, HemaSphere.

Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms.

M. Deininger, T. Tashi, 2023, Immunology and allergy clinics of North America.

Preliminary Safety and Efficacy from Apex, a Phase 2 Study of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Adults with Advanced Systemic Mastocytosis (AdvSM)

T. Tashi, C. Ustun, V. Pullarkat, 2022, Blood.

Role of chemotherapy in the very elderly patients with metastatic pancreatic cancer — A Veterans Affairs Cancer Registry analysis ☆

I. Aldoss, T. Tashi, A. Ganti, 2011 .

Genitourinary small cell carcinoma: Analysis of clinical and treatment factors associated with survival among patients in the Veterans Affairs Health System.

I. Aldoss, T. Tashi, S. Subbiah, 2010 .

Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer

C. Huff, A. Sapkota, Hao Hu, 2016, Oncotarget.

Prognostic Implications of Lymphadenectomy in Esophageal Cancer After Neo-adjuvant Therapy: a Single Center Experience

T. Tashi, X. Fang, M. Hoshino, 2011, Journal of Gastrointestinal Surgery.

Avapritinib versus Placebo in Indolent Systemic Mastocytosis.

M. Triggiani, I. Dybedal, T. Tashi, 2023, NEJM evidence.

Seliciclib in malignancies

I. Aldoss, T. Tashi, A. Ganti, 2009, Expert opinion on investigational drugs.

Systemic amyloidosis masquerading as iron deficiency anemia

T. Tashi, S. Subbiah, W. Gonsalves, 2012, Indian Journal of Gastroenterology.

Assessment of prognostic factors after primary tumor resection in metastatic colon cancer patients: A Veteran's Affairs Central Cancer Registry (VACCR) analysis, 1995–2008

T. Tashi, A. Ganti, P. Silberstein, 2012, Journal of surgical oncology.